AI Breakthrough Accelerates Discovery of GPCR-Targeting Antibodies
Summary:
Researchers use artificial intelligence to rapidly design potent antibodies that can both block and activate G protein-coupled receptors, revolutionizing drug development.
Trump’s Bold Drug Price Control Plan Faces Uncertain Implementation Path
Summary:
Trump orders “most-favored nation” pricing to reduce US drug costs by 30-80%, but legal challenges and industry opposition raise questions about feasibility.
Radiopharmaceuticals: The $16 Billion Revolution in Precision Cancer Treatment
Summary:
Pharmaceutical giants race to innovate with targeted radiation therapies, combining precision targeting with powerful alpha emitters to transform oncology care.
Trump Administration’s Radical Restructuring of NSF Threatens U.S. Research
Summary:
NSF faces unprecedented transformation with budget cuts, grant terminations, and focus shifted to five priority areas, undermining basic research across disciplines.
OpenAI’s Reasoning Models: Transforming Scientific Research
Summary:
OpenAI’s new reasoning tools enhance research capabilities while raising questions about computation costs and proprietary limitations.
